Can-Fite BioPharma Ltd. (TLV:CANF)
1.000
0.00 (0.00%)
Oct 5, 2025, 12:01 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 47.32 million as of October 7, 2025. Its market cap has decreased by -10.78% in one year.
Market Cap
47.32M
Enterprise Value
25.87M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 47.32M, an increase of 195.04%. That is a compound annual growth rate of 5.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 5, 2025 | 47.32M | -16.52% |
Dec 31, 2024 | 56.68M | 77.98% |
Dec 31, 2023 | 31.85M | -53.53% |
Dec 29, 2022 | 68.52M | -42.86% |
Dec 30, 2021 | 119.91M | 29.93% |
Dec 31, 2020 | 92.29M | 106.23% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 74.99B |
Danel (Adir Yeoshua) | 3.10B |
Kamada | 1.31B |
Bait Bakfar | 1.01B |
BrainsWay | 977.55M |
SofWave Medical | 960.10M |
Ilex Medical | 714.47M |
Novolog (Pharm-Up 1966) | 649.83M |